News
Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after stopping their prescription, ...
33m
News-Medical.Net on MSNWeight regain observed in patients after ending obesity drug treatmentPatients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...
GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little evidence of improving cardiorespiratory fitness, researchers say.
Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
Mounjaro side effect explained as more than 220,000 Brits are expected to receive the drug over the next three years ...
Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...
Morrisons has opened its own weight loss subscription, selling tirzepatide injections – also known as Mounjaro – to help ...
An injection drug known as tirzepatide, already approved by the FDA for treating Type 2 diabetes, is likely to gain approval for weight loss treatment this year. Here's what to know.
“Weight loss quality is a new concept….The discussion no longer revolves around the lack of adequate efficacy but rather ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results